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Abstract
We examine whether feeding pregnant and lactating rats hydrogenated fats rich in trans fatty acids
modifies the plasma lipid profiles and the expression of adipokines involved with insulin resistance
and cardiovascular disease in their 90-day-old offspring. Pregnant and lactating Wistar rats were fed
with either a control diet (C group) or one enriched with hydrogenated vegetable fat (T group).
Upon weaning, the male pups were sorted into four groups: CC, mothers were receiving C and
pups were kept on C; CT, mothers were receiving C and pups were fed with T; TT, mothers were
receiving T and pups were kept on T; TC, mothers were receiving T and pups were fed with C.
Pups' food intake and body weight were quantified weekly and the pups were killed at day 90 of life
by decapitation. Blood and carcass as well as retroperitoneal, epididymal, and subcutaneous white
adipose tissues were collected. Food intake and body weight were lower in TC and TT, and
metabolic efficiency was reduced in TT. Offspring of TT and TC rats had increased white adipose
tissue PAI-1 gene expression. Insulin receptor was higher in TT than other groups. Ingestion of
hydrogenated vegetable fat by the mother during gestation and lactation could promote deleterious
consequences, even after the withdrawal of the causal factor.
Introduction
Nutritional conditions during gestation have a major role
in the metabolic and hormonal interactions between the
maternal body, placenta, and fetus. The fetus growth is
influenced by the maternal nutritional condition. Fetal
insulin and insulin growth factor (IGF) have major roles
in the regulation of growth, and respond rapidly to
changes in fetal nutrition [1].
During gestation, changes in the maternal metabolism
occur in order to supply nutrition to the fetus. Lipids play
a fundamental role in fetal development. Although lipids
transfer through placenta is very limited, changes in die-
tary fatty acids can lead to implications in fetal and post-
natal development [2].
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Metabolic programming occurs during the period of intra-
uterus development. Inadequate nutritional and environ-
mental factors may modify the fetal metabolic program-
ming which could be reflected as deleterious
consequences in adulthood, such as predisposition to
develop cardiovascular and metabolic diseases [3-5].
Albuquerque et al [6] suggest that the exposition to trans
fatty acids (TFA) during gestation and lactation can have
harmful consequences to the offspring in adulthood. The
levels of TFA in maternal milk are directly correlated to the
maternal diet during gestation and lactation [7].
The chronic ingestion of hydrogenated vegetable fat rich
in TFA and saturated fatty acids modifies the serum lipid
profile, increases the risk of cardiovascular diseases, and
reduces insulin sensitivity, leading to type 2 diabetes [8-
10]. Also, Ibrahim et al [10] demonstrated that treatment
with TFA has a much greater effect in decreasing adipocyte
insulin sensitivity than treatment with saturated fatty
acids. This result was in part explained by a reduction of
plasma membrane fluidity in the rats treated with TFA.
Increases in PAI-1 serum concentrations are related to
insulin resistance [11,12] and the incidence of cardiovas-
cular diseases in obesity [13-16].
Several studies in the literature have reported decreased
adiponectin serum levels in patients with insulin resist-
ance and type 2 diabetes mellitus, obesity and heart dis-
ease [17,18]. It has been demonstrated that adiponectin
reduces hepatic production of glucose and the concentra-
tion of triglycerides in the muscles, thus ameliorating
insulin sensitivity [19].
On the other hand, only a few studies have described the
effects of the ingestion of TFA during gestation and lacta-
tion on the metabolism of offspring in adulthood. In this
study we investigated the effects on 90-day-old offspring
of maternal ingestion of a diet enriched with partially
hydrogenated vegetable oil, rich in TFA, from the begin-
ning of gestation through lactation, with continued expo-
sure after weaning until the 90th day of life. The effects of
this diet were also studied when the offspring were
exposed to this diet during gestation and lactation only, or
just after weaning. Some parameters of the metabolism
were analyzed, as well as the gene expression of adi-
pokynes involved with insulin resistance and cardiovascu-
lar diseases.
Methods
Animals and treatments
The Experimental Research Committee of the São Paulo
Federal University approved all procedures for the care of
the animals used in this study. Rats were kept under con-
trolled conditions of light (12:12 h light-dark cycle with
lights on at 07:00) and temperature (24 ± 1°C). Three-
month-old female Wistar rats were left overnight to mate,
and copulation was verified the following morning by the
presence of sperm in the vaginal smears. On the first day
of gestation, rats were isolated in individual cages and ran-
domly divided into two groups, receiving either a control
diet (C) or a diet enriched with hydrogenated vegetable fat
(T). The diets were maintained throughout gestation and
lactation. On the day of delivery, considered as day zero
of lactation, each mother was given eight male pups. On
the 21st day of life the animals were weaned and the pups
were divided in four groups: CC, mothers fed C diet and
pups fed C diet; CT, mothers fed C diet and pups fed T
diet; TT, mothers fed T diet and pups fed T diet; TC, moth-
ers fed T diet and pups fed C diet.
Both diets were prepared according to the recommenda-
tions of the American Institute of Nutrition (AIN-93 G
and M) [20], being similar in calories and lipid content.
The source of lipids for the C diet was soybean oil, and the
principal source for the T diet was partially hydrogenated
vegetable fat, rich in TFA. The centesimal composition of
the diets is presented in Table 1. The fatty acid profile of
each diet, presented in Table 2, was analyzed in the Labo-
Table 1: Composition of the control diet and diet enriched with 
trans fatty acids according to AIN-93
Diet (g/100 g)
Ingredient Control Trans
Casein* 20 (14) 20
L-cystine† 0.3 (0.18) 0.3
Cornstarch† 62 (71.1) 62
Soybean oil‡ 8 (5) 1
Hydrogenated vegetable fat$ -7
Butylhydroquinone† 0.0014 (0.0008) 0.0014 (0.0008)
Mineral mixture§ 3.5 3.5
Vitamin mixture# 1.0 1.0
Cellulose† 5.0 5.0
Choline bitartrate† 0.25 0.25
Energy (kcal/g) 4.0 (3.8) 4.0 (3.8)
The first number refers to the growth diet (AIN-93G) and the number 
in parentheses refers to maintenance diet (AIN-93M) when its 
composition differed from that of the growth diet. *Casein was 
obtained from CoperLab, São Paulo, Brazil. †L-cystine, cornstarch, 
butylhydroquinone, cellulose and choline bitartrate were obtained from 
Viafarma, São Paulo, Brazil. ‡Oil was supplied from soybean (Lisa/Ind. 
Brazil). $Hydrogenated vegetabke fat was supplied from Unilever, São 
Paulo, Brazil. £Mineral mix 9mg/kg diet): calcium, 5000; phosphorus, 
1561; potassium, 3600; sodium, 1019; chloride, 1571; sulfur, 300; 
magnesium, 507; iron, 35; copper, 6.0; manganese, 10.0; zinc, 30.0; 
chromium, 1.0; iodine 0.2; selenium, 0.15; fluoride, 1.00; boron, 0.50; 
molybdenum, 0.15; silicon, 5.0; nickel, 0.5; lithium, 0.1; vanadium, 0.1 
(AIN-93G mineral mix DYETS 210025, Dyets Inc., Bethlehem, PA, 
USA). #Vitamin mix (mg/kg diet): thiamin HCL, 6.0, riboflavin, 6.0; 
pyridoxine HCL 7.0; niacin, 30.0; calcium pantothenate, 16.0; folic acid, 
2.0; biotin, 0.2; vitamin B12, 25.0; vitamin A palmitate 4000 IU; vitamin E 
acetate, 75; vitamin D3, 1000 IU; vitamin KI, 0.75. (AIN-93G, vitamin 
mix, DYETS 310025, Dyets Inc., Bethlehem, PA, USA)Lipids in Health and Disease 2008, 7:13 http://www.lipidworld.com/content/7/1/13
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ratory of Food Composition, Federal University of Rio de
Janeiro (RJ, Brazil), using gas chromatography.
Fatty acid composition of the diet
For lipid extraction, saponification, and fatty acid methyl-
ation, 500 mg of the prepared diets were treated with 2.0
ml of methanol:benzene (4:1, v/v) followed by 200 μl of
acetyl chloride under light agitation. Fatty acid methyl
esters were separated (SP2560 column, Supelco, Belle-
fonte, PA, USA) and quantified by gas-liquid chromatog-
raphy with an ionizable flame detector (Perkin, Wellesley,
MA, USA) and hydrogen as the carrier gas. Injection and
detection temperatures were 260°C and 280°C, respec-
tively. The run temperature started at 135°C and
increased up to 195°C, with a run time of 45 minutes, as
described by Albuquerque et al [6].
Experimental procedures
The offspring were weighed weekly from days 21 to 90 of
life, when they were killed by decapitation. Trunk blood
was collected and immediately centrifuged. Serum was
separated and stored at -70°C for later determination of
triglycerides, cholesterol, HDL-cholesterol, glucose, insu-
lin, adiponectin, and leptin. The retroperitoneal (RET),
epididymal (EPI) and subcutaneous (SUB) white adipose
tissues were partially dissected, immediately frozen in liq-
uid nitrogen, stored at -70°C, and used for quantification
of adiponectin and PAI-1 mRNA. Leftover fat depots were
immediately immerged in adequate buffer for total pro-
tein extraction, to allow quantification of insulin receptor.
Carcass lipid and protein content
A further group of CC, CT, TC, and TT rats was used for the
determination of the carcass lipid and protein content.
Carcasses were eviscerated, weighed, and stored at -20°C.
Lipid content was measured as described by Stansbie et al
[21] and standardized using the method described by
Oller do Nascimento and Williamson [22]. Briefly, the
eviscerated carcass was autoclaved at 120°C for 90 min-
utes and homogenized with double the mass of water.
Triplicate aliquots of this homogenate were weighed and
digested in 3 ml of 30% KOH and 3 ml of ethanol for at
least 2 hours at 70°C in capped tubes. After cooling, 2 ml
of 12N H2SO4 were added and the sample was washed
three times with petroleum ether for lipid extraction.
Results are expressed as grams of lipid per 100 g of carcass.
For protein measurements, aliquots of the same homoge-
nate (approximately 1 g) were heated to 37°C for 1 hour
in 0.6N KOH with constant shaking. After clarification by
centrifugation, protein content was measured according
to the method described by Lowry et al [23].
RNA extraction and Northern blot analysis
Total RNA was extracted with Tri-Reagent (Sigma), and its
concentration was determined from absorbance at 260
nm.
Adiponectin mRNA from RET was quantified by Northern
blot analysis, using an antisense oligonucleotide (5'-GTT-
GCAGTGGAATTTGCCAGTGCCGTCA-3) based on the rat
adiponectin cDNA sequence (PubMed), synthesized as a
hybridization probe and end-labeled (5'-end) with a dig-
oxigenin ligand (MWG, USA), as described by Trayhurn et
al [24].
Twenty-microgram aliquots of RNA were run in 1% agar-
ose-formaldehyde gel at 80–100 V, blotted overnight onto
a positively charged nylon membrane (Roche), cross-
linked under UV light, pre-hybridized with hybridization
buffer (5 × SSC, 50 mM sodium phosphate, 2% blocking
reagent, 0.1% N-lauroylsarcosine, 7% SDS, all from
Sigma), and hybridized overnight at 42°C with the same
buffer with an added rat adiponectin probe at a 25 ng/ml
final concentration. Following post-hybridization washes,
membranes were incubated with an antibody against dig-
oxigenin (Fab-fragment; Roche) for 30 minutes and then
with CDP-Star chemiluminescence substrate (Roche) for
10 minutes at room temperature. Signals were collected
by exposure to film for 5–30 minutes at room tempera-
ture. After probing for adiponectin mRNA, blots were
stripped and re-probed for 18S rRNA. The sequence of the
antisense oligonucleotide 18S rRNA was described previ-
ously [25]. Blots were quantified by densitometry using
Image J software. Results are presented as the mRNA/18S
rRNA ratio and expressed as arbitrary units.
Table 2: Fatty acid composition of the diets
Percentage of total fatty acids
Fatty acid Control Trans
C14:0 0.60 0.85
C16:0 12.88 15.70
C18:0 3.88 13.77
C14:1 0.49 0.60
C18:1 n-9 trans ND 11.62
C18:1 n-9 cis 22.45 24.15
C18:2 n-6 trans ND 0.43
C18:2 n-6 (linoleic) 52.90 24.59
C18:3 n-3(α-linolenic) 5.41 1.51
Total SFA 17.36 30.32
Total MUFA-cis 22.94 24.75
Total PUFA-cis 58.31 26.10
Total TFA ND 12.05
PUFA:SFA 3.35 0.86
n-6:n-3 9.78 16.28
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, 
polyunsaturated fatty acids; ND, not detected, TFA, trans fatty acids.Lipids in Health and Disease 2008, 7:13 http://www.lipidworld.com/content/7/1/13
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Real-time polymerase chain reaction
PAI-1 mRNA from RET and EPI was quantified by real-
time polymerase chain reaction (PCR). RNA samples were
previously treated with DNAse (DNA-free, Ambion, UK).
One microgram of each sample was reverse transcribed
using an M-MLV Reverse Transcriptase kit (Promega), and
cDNA was synthesized in a final volume of 50 μl. The rel-
ative level of PAI-1 mRNA was quantified in real time,
using a SYBR Green primer in an ABI Prism 7700
Sequence Detector (both from Applied Biosystems). The
relative level of the housekeeping gene hypoxanthine
phosphoribosyltransferase (HPRT) was measured. The
primers used were: PAI-1,
5'ACAGCCTTTGTCATCTCAGCC3' (sense) and
5'CCGAACCACAAAGAGAAAGGA3' (antisense); and
HPRT, 5'CTCATGGACTGATTATGGACAGGA3' (sense)
and 5'GCAGGTCAGCAAAGAACTTATAGC3' (antisense).
Results were obtained using Sequence Detector software
(Applied Biosystems) and are expressed as a relative
increase, using the method of 2-ΔΔCt described by Livak
and Schmittgen [26].
Quantification of insulin receptor by Western blotting
Samples of EPI and SUB were rapidly dissected and
homogenized in 1 ml of chilled extraction buffer (100
mM Trizma Base pH 7.5; 10 mM EDTA; 100 mM NaF; 10
mM Na4P2O7; 10 mM Na3VO4; 2 mM PMSF; 0.1 mg/ml
aprotinin). After homogenization, 100 μl of 10% Triton
X-100 was added to the samples, which were left in ice for
30 minutes and then centrifuged (12,000 rpm, 20 min-
utes, 4°C). From each sample, 80 μg of protein in a 20 μl
volume were loaded into a polyacrylamide gel containing
0.1% SDS, separated by electrophoresis, and then elec-
troblotted onto a nitrocellulose membrane. Membranes
were incubated with rabbit anti-rat primary antibody
against insulin receptor (SC-711), followed by washings
and incubation with goat anti-rabbit IgG-horseradish per-
oxidase (Sigma, USA). The labeled protein was detected
by the chemiluminescent substrate ECL (Amersham) and
exposed to Hyper-film ECL (Amersham). The protein
bands were identified according to their migration in
comparison to the rainbow recombinant protein molecu-
lar weight markers and quantified by densitometry using
Image J software. Membranes were treated with specific
buffers to remove previously linked antibodies, incubated
with anti-β actin, and measured again. Results are
expressed as arbitrary units, relative to β-actin values.
Biochemical and hormonal serum analysis
Glucose, triglycerides, total cholesterol, and HDL-choles-
terol serum concentrations were measured by an enzy-
matic colorimetric method using commercial kits
(Labtest, Brazil). Insulin, adiponectin, and leptin concen-
trations were quantified using specific enzyme-linked
immunosorbent assay (ELISA) kits (Linco Research, USA).
Statistical analysis
All results are presented as means ± standard error of the
mean (SE). Statistical significances of the differences
between the means of the four groups of samples were
assessed using one-way analysis of variance (ANOVA),
followed by the Tukey's test. Differences were considered
to be significant when p < 0.05.
Results
The body weights of the pups at 21 days old did not differ
between the C and T groups. However, both the group TC
at the seventh week and the group TT at the fourth week
after weaning (Figure 1A) had lower body weights com-
pared with CC. The total body weight gain in CC was
higher than TT, TC and CT (Figure 1B). Also, TT had
increase in total body weight gain as compared to TC
group (Figure 1B). However, the food intake of both TT
and TC was lower than CC and CT (Figure 1C).
The metabolic efficiency was higher in the TT group in
relation to the other groups: for each gram of body weight
gained, the TT ingested around 2.5 g of diet, whereas the
other groups ingested around 3.2 g of diet (Figure 1D).
The food intake of groups TC and TT was lower than CC
(Table 3).
The exposure to TFA after weaning (namely CT and TT
groups) caused an approximate 40% increase in the body
fat content (Figure 2A), however, the other corporal
parameters measured (body protein content, RET and EPI
relative weight) were no different among the groups (Fig-
ure 2).
Glycemia, lipid profile and leptin blood levels were simi-
lar among the studied groups. However, adiponectin
blood levels were increased in TT (by 69%) and TC (by
34%) groups and insulinemia was higher in TT (by 84%)
compared with the control group (Table 4).
Adiponectin gene expression in RET of the CT group was
higher than in the CC group (Figure 3). On the other
hand, a decrease was observed in PAI-1 gene expression in
the CT group (Fig 4A) compared with the other groups.
PAI-1 gene expression in EPI was increased in the TT and
TC groups (215% and 175% higher, respectively) com-
pared with the CC and CT groups (Figure 4B). In this tis-
sue, a higher protein level of insulin receptor (IR) was
found in the CT compared with the CC and TT groups
(Figure 5A).Lipids in Health and Disease 2008, 7:13 http://www.lipidworld.com/content/7/1/13
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(A) Body weight Figure 1
(A) Body weight. (B) Total body weight gain. (C) Total food intake. (D) metabolic efficiency. CC, mothers fed C 
diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; 
TC, mothers fed T diet and offspring fed C diet. The number of studied animals per each group is 10. Data are means ± SE of 
10 determinations per group. *p < 0.05, TT compared with CC. #p < 0.05, TC compared with CC.
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Thus, treatment with the T diet from gestation to the end
of the period studied (group TT) caused an increase in IR
protein levels in SUB (Figure 5B).
Discussion
In this study, the effects of maternal ingestion of hydro-
genated vegetable fat rich in TFA, during gestation and lac-
tation, followed by continued exposure of the offspring to
this diet after weaning until the 90th day of life were
investigated. We have also analyzed the effects of exposure
to this diet just after weaning.
The food intake of the TC and TT groups was lower than
the CC group, demonstrating that the ingestion of TFA by
the mother during gestation and lactation can affect the
feeding behavior of the offspring from 21 to 90 days of
life.
Albuquerque et al [6] suggested that early exposure to TFA
promoted adaptations in the hypothalamic mechanisms
controlling food intake, and that these adaptations prob-
ably became programmed.
Wang et al [27] verified that the treatment with a high-fat
diet rich in n-6 polyunsaturated fatty acids (PUFA)
increased the gene expression of neuropeptide Y (NPY) in
(A) Carcass fat content Figure 2
(A) Carcass fat content. (B) Carcass protein content. (C) RET weight. (D) EPI weight. CC, mothers fed C diet and 
offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; TC, moth-
ers fed T diet and offspring fed C diet. Data are means ± SE of 10 determinations per group. p < 0.05.
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Table 3: Food intake (in grams per week)
Week CC CT TC TT
1a 67.3 ± 3.1a 58.3 ± 2.8ab 64.7 ± 3.0a 49.9 ± 1.4b
2a 108.3 ± 3.2a 91.7 ± 5.8a 72.9 ± 4.7b 94.3 ± 1.8a
3a 127.12 ± 5.4a 119.8 ± 5.2a 91.7 ± 5.9b 75.5 ± 4.1b
4a 158.4 ± 6.0a 120.3 ± 9.1b 100.3 ± 4.5b 101.6 ± 4.5b
5a 141.5 ± 5.71a 129.1 ± 6.9ab 113.0 ± 3.5bc 100.5 ± 3.8c
6a 153.9 ± 6.3a 132.8 ± 6.2ab 117.0 ± 5.1b 123.3 ± 5.4b
7a 145.1 ± 6.7a 141.0 ± 6.1a 96.57 ± 4.2b 137.3 ± 6.3a
8a 140.7 ± 4.3ac 117.1 ± 7.5ab 108.6 ± 4.7b 141.5 ± 6.1c
CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C 
diet and offspring fed T diet; TT, mothers fed T diet and offspring fed 
T diet; TC, mothers fed T diet and offspring fed C diet. Data are 
means ± SE of 10 determinations per group. p < 0.05. Values in the 
same line with different superscript letters are significantly different 
from one another at P < 0.05.Lipids in Health and Disease 2008, 7:13 http://www.lipidworld.com/content/7/1/13
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the arcuate nucleus of mice, as compared with mice
treated with a high-fat diet rich in saturated fatty acids.
Since, the T diet contained TFA and saturated fatty acids
and a low amount of n-3 and n-6 PUFA, in comparison
with the control diet, it is possible to suggest that the TC
and TT groups present low production of NPY and, as a
consequence, hypophagia in relation to the control group.
Likewise, Albuquerque et al [6] verified that the maternal
ingestion of TFA reduced the concentrations of arachi-
donic acid, docosahexaenoic acid and total PUFA content
in the total lipids of the brain obtained from 21-day-old
offspring.
The ingestion of TFA reduced body weight gain. However,
the TT group had the highest metabolic efficiency. These
results suggest that the treatment, from fetal life until
adulthood, with a diet rich in TFA and saturated fatty acids
can reduce energy expenditure. Supporting this sugges-
tion, Takeuchi et al [28] demonstrated that diet-induced
thermogenesis is high in rats treated with a PUFA-rich diet
compared with a diet rich in saturated fatty acids.
The carcass lipid content in the CT and TT groups was
higher than in the CC group. Similar findings were
described by Takeuchi et al [28] in animals treated with a
diet rich in saturated fatty acids. Furthermore, Shillabeer
and Lau [29] demonstrated that diets rich in saturated
fatty acids promote the replication of adipocytes. It is pos-
sible that this mechanism contributed to the high carcass
lipid content found in the CT and TT groups.
In a previous study, our group detected a dyslipidemia in
the 21-day-old offspring of mothers treated with TFA [30],
although the lipid profile was similar among groups in
the 90-day-old rats used in the present study. Gutman et
al [31] reported that the increased plasma triglyceride lev-
els caused by the ingestion of high amounts of sucrose is
multiphasic and depends on the period of treatment. This
treatment was found to increase triglyceridemia progres-
sively until the 22nd to 25th day of treatment, reduces to
normal levels at the 45th to 50th day, and increases again
at the 75th to 90th day of treatment. In this sense, it was
demonstrated that rats fed with diets rich in TFA and sat-
urated fatty acids for 12 weeks presented with increase
serum insulin, triglyceride, and cholesterol levels [10].
These findings support our results and thus we cannot
rule out the possibility that metabolic processes adapt to
changes in the dietary components in a specific period of
life.
Table 4: Serum glucose, triglycerides, total cholesterol, HDL-cholesterol, leptin, adiponectin and insulin
CC CT TT TC
Glucose (mg/dl) 118.7 ± 4.7a 98.8 ± 6.3a 108.4 ± 2.0a 101.8 ± 2.0a
Triglycerides (mg/dl) 125.0 ± 13.5a 126.0 ± 15.8a 166.5 ± 11.6a 147.9 ± 12.2a
Cholesterol (mg/dl) 106.6 ± 11.5a 110.5 ± 9.5a 107.9 ± 8.4a 125.9 ± 5.8a
HDL-cholesterol (mg/dl) 55.2 ± 6.3a 62.4 ± 5.7a 53.4 ± 3.9a 66.0 ± 6.0a
Cholesterol/HDL-cholesterol 1.9 ± 0.05a 1.8 ± 0.04a 2.0 ± 0.1a 2.0 ± 0.1a
Leptin (ng/ml) 10.10 ± 0.77a 8.80 ± 0.67a 9.23 ± 1.01a 7.18 ± 1.46a
Adiponectin (μg/ml) 51.33 ± 4.71a 51.23 ± 4.32a 86.53 ± 3.79b 68.60 ± 6.37c
Insulin (ng/ml) 1.23 ± 0.20a 1.95 ± 0.39b 2.26 ± 0.25b 1.80 ± 0.34ab
CC, mothers fed C diet and offspring fed C diet; CT, mothers fed C diet and offspring fed T diet; TT, mothers fed T diet and offspring fed T diet; 
TC, mothers fed T diet and offspring fed C diet. Data are means ± SE of 10 determinations per group. p < 0.05. Values in the same line with 
different superscript letters are significantly different from one another at P < 0.05.
Adiponectin mRNA quantification in retroperitoneal white  adipose tissue Figure 3
Adiponectin mRNA quantification in retroperitoneal 
white adipose tissue. CC, mothers fed C diet and offspring 
fed C diet; CT, mothers fed C diet and offspring fed T diet; 
TT, mothers fed T diet and offspring fed T diet; TC, mothers 
fed T diet and offspring fed C diet. Data are means ± SE of 
six determinations per group. Results are expressed in arbi-
trary units, stipulating 100 as the control value. p < 0.05.
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Furthermore, a high adiponectin serum level was found in
the TT and TC groups, which could be considered as a nor-
mal lipid profile, since it was described previously that
adiponectin stimulates fatty acid oxidation and adiponec-
tin serum level negatively correlates with triglyceride
serum level [32].
The TT group had normoglycemia, increased insulin
serum levels, and protein levels of IR in SUB. It has been
shown that increased adiponectin levels are associated
with a better glucose-level control in diabetics [33]. It is
therefore reasonable to suggest that the increased serum
adiponectin level associated with hyperinsulinemia and
IR protein levels could contribute to the maintenance of
glucose serum levels in the TT group.
The increase in PAI-1 gene expression in adipocytes was
associated with insulin resistance [34] and hyperinsuli-
naemia [35]. This could partially explain the increases in
PAI-1 mRNA (215%) in EPI of the TT group. However, we
also found an increase in PAI-1 mRNA levels in EPI of the
TC group compared with the CC group. Previously, we
found high PAI-1 mRNA levels in 21-day-old offspring of
rats fed a diet containing hydrogenated vegetable fat dur-
ing gestation and lactation [30]. These results suggested
that early exposure to hydrogenated vegetable fat caused
an alteration in adipose tissue PAI-1 gene expression and
that this alteration became programmed. Enhanced
expression of the PAI-1 gene in visceral fat correlates with
increased plasma levels [36] and a positive correlation
between PAI-1 levels and cardiovascular disease is well
described in the literature [11,37].
In summary, in this study we have found increased levels
of insulin, adiponectin, body fat, and epididymal adipose
tissue PAI-1 mRNA levels in 90-day-old offspring of rats
fed a diet containing hydrogenated vegetable fat during
Quantification of insulin receptor in (A) epididymal and (B)  subcutaneous white adipose tissues Figure 5
Quantification of insulin receptor in (A) epididymal 
and (B) subcutaneous white adipose tissues. CC, 
mothers fed C diet and offspring fed C diet; CT, mothers fed 
C diet and offspring fed T diet; TT, mothers fed T diet and 
offspring fed T diet; TC, mothers fed T diet and offspring fed 
C diet. Data are means ± SE of six determinations per group. 
Results are expressed in arbitrary units, stipulating 1 as the 
control value. p < 0.05.
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PAI-1 mRNA quantification in (A) retroperitoneal and (B)  epididymal white adipose tissues Figure 4
PAI-1 mRNA quantification in (A) retroperitoneal 
and (B) epididymal white adipose tissues. CC, mothers 
fed C diet and offspring fed C diet; CT, mothers fed C diet 
and offspring fed T diet; TT, mothers fed T diet and offspring 
fed T diet; TC, mothers fed T diet and offspring fed C diet. 
Data are means ± SE of six determinations per group. Results 
are expressed in arbitrary units, stipulating 100 as the control 
value. p < 0.05.
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gestation and lactation and exposed to the same diet after
weaning (TT group). The trans offspring exposed to the
control diet after weaning (TC group) also had an increase
in adiponectin serum concentration and PAI-1 mRNA lev-
els in EPI. These alterations were not observed in the CT
group. It has been hypothesized that these conditions are
produced by programming resulting from early exposure
to dietary hydrogenated fat which could promote delete-
rious consequences, even after the withdrawal of the
causal factor. TFA were probably important determinants
of these alterations. However, it cannot be ruled out that
differences in saturated and essential fatty acid contents
between the control and the TFA diets played a role.
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